Spark Therapeutics Enters into Licensing Agreement with Genethon – GlobeNewswire (press release)
Spark Therapeutics Enters into Licensing Agreement with GenethonGlobeNewswire (press release)PHILADELPHIA and EVRY, France, Sept. 20, 2017 (GLOBE NEWSWIRE) — Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challe… Continue reading
